Innovative biomedical and technological strategies for the control of bacterial growth and infections
| dc.contributor.author | Morais, Ana Heloneida de Araújo | |
| dc.contributor.author | Matias, Lídia Leonize Rodrigues | |
| dc.contributor.author | Damasceno, Karla Suzanne Florentino da Silva Chaves | |
| dc.contributor.author | Pereira, Annemberg Salvino | |
| dc.contributor.author | Passos, Thaís Souza | |
| dc.date.accessioned | 2024-04-12T20:29:38Z | |
| dc.date.available | 2024-04-12T20:29:38Z | |
| dc.date.issued | 2024-01 | |
| dc.description.resumo | Antibiotics comprise one of the most successful groups of pharmaceutical products. Still, they have been associated with developing bacterial resistance, which has become one of the most severe problems threatening human health today. This context has prompted the development of new antibiotics or co-treatments using innovative tools to reverse the resistance context, combat infections, and offer promising antibacterial therapy. For the development of new alternatives, strategies, and/or antibiotics for controlling bacterial growth, it is necessary to know the target bacteria, their classification, morphological characteristics, the antibiotics currently used for therapies, and their respective mechanisms of action. In this regard, genomics, through the sequencing of bacterial genomes, has generated information on diverse genetic resources, aiding in the discovery of new molecules or antibiotic compounds. Nanotechnology has been applied to propose new antimicrobials, revitalize existing drug options, and use strategic encapsulating agents with their biochemical characteristics, making them more effective against various bacteria. Advanced knowledge in bacterial sequencing contributes to the construction of databases, resulting in advances in bioinformatics and the development of new antimicrobials. Moreover, it enables in silico antimicrobial susceptibility testing without the need to cultivate the pathogen, reducing costs and time. This review presents new antibiotics and biomedical and technological innovations studied in recent years to develop or improve natural or synthetic antimicrobial agents to reduce bacterial growth, promote well-being, and benefit users | pt_BR |
| dc.identifier.citation | MATIAS, Lídia Leonize Rodrigues; DAMASCENO, Karla Suzanne Florentino da Silva Chaves; PEREIRA, Annemberg Salvino; PASSOS, Thaís Souza; MORAIS, Ana Heloneida de Araujo. Innovative biomedical and technological strategies for the control of bacterial growth and infections. Biomedicines, [S.l.], v. 12, n. 1, p. 176, 13 jan. 2024. DOI: 10.3390/biomedicines12010176. Disponível em: https://www.mdpi.com/2227-9059/12/1/176. Acesso em: 10 abr. 2024. | pt_BR |
| dc.identifier.doi | http://dx.doi.org/10.3390/biomedicines12010176 | |
| dc.identifier.uri | https://repositorio.ufrn.br/handle/123456789/58127 | |
| dc.language | en | pt_BR |
| dc.publisher | Biomedicines | pt_BR |
| dc.rights | Attribution 3.0 Brazil | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/br/ | * |
| dc.subject | Antimicrobial agents | pt_BR |
| dc.subject | Antibiotics | pt_BR |
| dc.subject | Nanotechnology | pt_BR |
| dc.subject | Genomics | pt_BR |
| dc.subject | Bioinformatics | pt_BR |
| dc.title | Innovative biomedical and technological strategies for the control of bacterial growth and infections | pt_BR |
| dc.type | article | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- InnovativeBiomedical_Matias_2024.pdf
- Tamanho:
- 2.52 MB
- Formato:
- Adobe Portable Document Format
Nenhuma Miniatura disponível
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.45 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível